Home・Listă Acțiuni・Pacira Pharmaceuticals Inc-DE

Pacira Pharmaceuticals Inc-DE

Închisă

SectorSănătate

27.59 3.41

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

26.19

Maxim

27.59

Indicatori cheie
By Trading Economics
Venit	1.3M 2.9M
Vânzări	-19M 177M
P/E Medie Sector	207.077 68.51
EPS	0.6
Marjă de profit	1.644
Angajați	825
EBITDA	5M 30M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+17.64% upside

Dividende
By Acuity
Următoarele câștiguri	5 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-40M 1.1B
Deschiderea anterioară	24.18
Închiderea anterioară	27.59

Sentimentul știrilor

By Acuity

50%

175 / 340 Clasament în Healthcare

Pacira Pharmaceuticals Inc-DE Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 aug. 2026, 19:53 UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

3 aug. 2026, 20:06 UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

31 iul. 2026, 20:02 UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

30 iul. 2026, 17:16 UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

29 iul. 2026, 20:04 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

28 iul. 2026, 19:56 UTC

Event

News

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

27 iul. 2026, 18:51 UTC

Event

News

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

24 iul. 2026, 17:16 UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

22 iul. 2026, 18:06 UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

21 iul. 2026, 19:56 UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

20 iul. 2026, 19:46 UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.

Comparație

Modificare preț

Pacira Pharmaceuticals Inc-DE Așteptări

Obiectiv de preț

By TipRanks

17.64% sus

Prognoză pe 12 luni

Medie 31.67 USD 17.64%

Maxim 38 USD

Minim 25 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPacira Pharmaceuticals Inc-DE - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

3 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 3 analiști care au acordat evaluări ale acțiunilor Pacira Pharmaceuticals Inc-DE - Dist în ultimele 3 luni.

Sentiment

By Acuity

175 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.